Ticker LaunchReverse merger · Completed · KA
Kineta Operating, Inc. (Kineta)
Reverse merger with Yumanity Therapeutics, Inc.
Kineta Operating, Inc. (Kineta) merged into Yumanity Therapeutics, Inc., a clinical-stage biopharmaceutical company that sold its YTX-7739 program to Janssen, in a reverse merger that takes the private company public. The deal was announced on Jun 5, 2022 and closed on Dec 16, 2022. The combined company trades as Kineta, Inc. (KA) on Nasdaq.
Kineta, Inc. is a clinical-stage biotechnology company developing next-generation immunotherapies that address cancer immune resistance.
- Status
- Completed
- Private company
- Kineta Operating, Inc. (Kineta)
- Public company
- Yumanity Therapeutics, Inc.
- Public company business before
- clinical-stage biopharmaceutical company that sold its YTX-7739 program to Janssen
- Announced
- Jun 5, 2022
- Closed
- Dec 16, 2022
- Combined company
- Kineta, Inc. (KA)
- Exchange
- Nasdaq
- Sector
- Biotech & pharma
More on this deal for subscribers
- Concurrent financing and investors
- Reverse stock split
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Closing 8-K Dec 22, 2022
- Closing press release / exhibit
- Announcement 8-K Mar 4, 2022
- All filings on EDGAR CIK 1445283
Other completed reverse mergers
- Ayala Pharmaceuticals, Inc.into Advaxis, Inc. · Jan 19, 2023
- Cambell International Holding Limitedinto Bitmis Corp. · Dec 30, 2022
- Exworth Union Incinto Strategic Acquisitions, Inc. · Dec 22, 2022
- AmeriGuard Security Services, Inc.into Health Revenue Assurance Holdings, Inc. · Dec 9, 2022
- Renewable Innovations, Inc.into Nestbuilder.com Corp. · Dec 1, 2022
- Fintech Scion Limitedinto HWGC Holdings Limited · Nov 30, 2022